Table 1. Patient characteristics.
| Characteristic | Arm A | Arm B | |
|---|---|---|---|
| q2w N = 40 | qw N = 12 | q2w N = 13 | |
| Median age (range), years | 65 (41–80) | 57 (25–65) | 61 (40–79) |
| Male, n (%) | 22 (55) | 5 (42) | 10 (77) |
| Race, n (%) | |||
| Asian | 2 (5) | 0 | 1 (8) |
| Black/African American | 2 (5) | 2 (17) | 0 |
| White | 35 (88) | 10 (83) | 12 (92) |
| Other | 1 (3) | 0 | 0 |
| ECOG, n (%) | |||
| 0 | 11 (28) | 5 (42) | 2 (15) |
| 1 | 27 (68) | 6 (50) | 10 (77) |
| 2 | 2 (5) | 1 (8) | 1 (8) |
| Primary cancer, n (%) | |||
| Colon/large intestine | 15 (38) | 0 | 4 (31) |
| Rectum | 8 (20) | 0 | 1 (8) |
| Breast | 2 (5) | 3 (25) | 0 |
| Melanoma | 3 (8) | 2 (17) | 1 (8) |
| Head and neck | 2 (5) | 0 | 2 (15) |
| Skin | 1 (3) | 1 (8) | 0 |
| Soft tissue | 1 (3) | 1 (8) | 0 |
| Uterus | 1 (3) | 1 (8) | 0 |
| Cervix | 1 (3) | 0 | 2 (15) |
| Esophagus, gastric, gastroesophageal junction | 3 (7) | 0 | 1 (8) |
| Kidney | 0 | 1 (8) | 0 |
| Pancreas | 0 | 1 (8) | 0 |
| Thymus | 1 (3) | 0 | 0 |
| Othera | 2 (3) | 1 (8) | 2 (15) |
| Median line of prior therapy (range) | 3.5 (0–9) | 3.5 (0–7) | 3.0 (1–7) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; qw, weekly; q2w, biweekly
a
“Other” includes bone, adenoid cystic carcinoma of glandula submandibularis, cholangiocarcinoma, chondrocarcinoma, ear, nasopharynx, and eye.